Publications of Yvonne Genzel
All genres
Talk (121)
161.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (7th Edition):Upstream Process Development - From Master Seed to Production. ESACT Course 2022, Llafranc (Spain) (2022)
162.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (7th Edition):Upstream Process Intensification. ESACT Course 2022, Llafranc (Spain) (2022)
163.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (7th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2022, Llafranc (Spain) (2022)
164.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (7th Edition): Exercise on vaccine design. ESACT Course 2022, Llafranc (Spain) (2022)
165.
Talk
Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)
166.
Talk
Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Value through intensified bioprocessing II, Oxford, United Kingdom (2022)
167.
Talk
Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. 27th ESACT Meeting, Lisbon (Portugal) (2022)
168.
Talk
Production of influenza A virus defective interfering particles in a high cell density perfusion cultivation with continuous virus harvesting. Vaccine Technology VIII, Sitges (Spain) (2022)
169.
Talk
Influenza A Virus-Derived Defective Interfering Particles for Antiviral Treatment. 27th ESACT Meeting, Lisbon (Portugal) (2022)
170.
Talk
Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)
171.
Talk
Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)
172.
Talk
Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)
173.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2021, Virtual Meeting (2021)
174.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2021, Virtual Meeting (2021)
175.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2021, Virtual Meeting (2021)
176.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2021, Virtual Meeting (2021)
177.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (6th Edition): Exercise on COVID-19 vaccines immunology and protection. ESACT Course 2021, Virtual Meeting (2021)
178.
Talk
Process intensification for virus production: stirred or shaken perfusion leads to very high titres. World Vaccine Congress Washington, Virtual Meeting (2020)
179.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2020, Virtual Meeting (2020)
180.
Talk
ESACT Course on Cell Culture-based Viral Vaccines (5th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2020, Virtual Meeting (2020)